What is the typical serum uric acid level in pregnancy‑induced hypertension (PIH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Serum Uric Acid Levels in Pregnancy-Induced Hypertension

Serum uric acid levels are elevated in pregnancy-induced hypertension (PIH), typically ranging from 5.5-6.5 mg/dL or higher, compared to normal pregnancy values of approximately 4.0-4.5 mg/dL. 1

Diagnostic Testing Recommendations

Major guidelines recommend measuring serum uric acid as part of the initial workup for hypertension in pregnancy:

  • The International Society for the Study of Hypertension in Pregnancy (ISSHP) recommends serum uric acid testing at first diagnosis of chronic hypertension in pregnancy to establish a baseline reference for detecting superimposed preeclampsia 1
  • The International Society of Hypertension guidelines include serum uric acid (s-UA) as part of the investigation panel for hypertension in pregnancy 1
  • Testing should be performed alongside full blood count, liver enzymes, serum creatinine, electrolytes, and urinalysis 1

Typical Uric Acid Values by Condition

The following ranges have been documented in research studies:

  • Normal pregnancy: 4.0-4.7 mg/dL 2, 3, 4
  • Mild PIH/gestational hypertension: 5.4-5.6 mg/dL 2, 3, 4
  • Severe PIH/preeclampsia: 6.2-6.7 mg/dL 2, 3, 4
  • PIH with HELLP syndrome: 6.8-7.4 mg/dL (382-412 μmol/L) 5

Clinical Significance and Interpretation

A serum uric acid level ≥5.5 mg/dL is considered an indicator of PIH and correlates with disease severity:

  • Levels ≥5.5 mg/dL show 79% sensitivity and 71% specificity for diagnosing PIH 2
  • In women with chronic hypertension, uric acid ≥5.5 mg/dL increases the likelihood of superimposed preeclampsia (likelihood ratio 2.5) 4
  • Elevated gestation-corrected uric acid levels are associated with worse maternal and fetal outcomes and should prompt detailed assessment of fetal growth 1

Important Clinical Caveats

While uric acid is elevated in PIH, guidelines emphasize specific limitations:

  • Serum uric acid is NOT a diagnostic criterion for preeclampsia and should not be used alone to determine timing of delivery 1
  • The test shows better diagnostic efficiency than creatinine for PIH (79% vs 63% sensitivity) but has limited utility in differentiating between various hypertensive disorders of pregnancy 2, 4
  • Uric acid levels do not reliably predict the severity of HELLP syndrome once it develops 5
  • The correlation between uric acid and clinical outcomes is weak (r = 0.06 to 0.26), though the association with severity of hypertension and proteinuria is stronger 5, 4

Practical Application

Use serum uric acid as part of a comprehensive assessment panel:

  • Obtain baseline uric acid at diagnosis of any hypertensive disorder in pregnancy 1
  • Values ≥5.5 mg/dL warrant increased surveillance for progression to preeclampsia, particularly in women with gestational hypertension or chronic hypertension 3, 4
  • Serial measurements can help monitor disease progression, though clinical decisions should be based on the complete clinical picture including blood pressure trends, proteinuria, symptoms, and laboratory markers 1
  • Hyperuricemia (>5.5 mg/dL) is associated with increased perinatal morbidity and mortality 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Significance of Serum Uric Acid in Pregnancy Induced Hypertension.

Journal of the National Medical Association, 2017

Research

Hyperuricemia and pregnancy induced hypertension--reappraisal.

Indian journal of medical sciences, 1996

Research

The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.